HoloSurge awarded €8.9M Horizon Europe grant to improve surgical planning with hologram technology
Summary
It is utilised by medical professionals to plan and customise operations according to the unique anatomical features of each patient.The Horizon Europe Programme, with a funding pot of approximately \xa380 billion, is dedicated to fostering research initiatives that concentrate on three core areas: excellent science, industrial leadership, and societal challenges. This tool not only facilitates more efficient and precise planning of operations but also allows surgeons to manipulate the hologrammoving, rotating, and expanding it to view the organ from various perspectives.Furthermore, colleagues equipped with these headsets can interact with the hologram simultaneously, whether they are in the same room or collaborating remotely. This includes issues such as infection, bleeding, organ damage and death which currently affect up to 48% of liver surgeries and 60% of pancreatic surgeries.Due to their two-dimensional nature, traditional imaging methods, such as ultrasound, MRI and CT scans, can also result in surgeons missing critical details. The team will ensure regulatory compliance, clinical validation, and technical optimisation for widespread adoption in liver and pancreatic cancer surgeries.Prof David Jayne, Professor of Surgery at the University of Leeds and Hon. Consultant Surgeon at Leeds Teaching Hospitals NHS Trust: The Holocare technology is an exciting advance in how we treat cancer patients with the potential to transform surgical care.